Pancreatic Cancer Research

ResearcherSecond People’s Hospital of Huai’anActive in the last 2 years

Chuang Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9300-4689; OpenAlex author ID A5100609149. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. Role of a novel circRNA-CGNL1 in regulating pancreatic cancer progression via NUDT4-HDAC4-RUNX2-GAMT-mediated apoptosis. First author DOI 10.1186/s12943-023-01923-7↗
  2. circPTPN22 attenuates immune microenvironment of pancreatic cancer via STAT3 acetylation. Co-author DOI 10.1038/s41417-021-00382-w↗
  3. ALKBH5-mediated m6A demethylation of KCNK15-AS1 inhibits pancreatic cancer progression via regulating KCNK15 and PTEN/AKT signaling. Last author DOI 10.1038/s41419-021-04401-4↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Changhong Lian · 2 shared papers, 2023–2024 · strength 0.37
  2. Yuan He · 2 shared papers, 2021–2023 · strength 0.31
  3. Huiqing Zhang · 1 shared paper, 2023 · strength 0.18
  4. Hao Hu · 1 shared paper, 2023 · strength 0.18
  5. Yufeng Zhang · 1 shared paper, 2024 · strength 0.18
  6. Hao Yuan · 1 shared paper, 2024 · strength 0.18
  7. Xinjian Liu · 1 shared paper, 2024 · strength 0.18
  8. Yuan He · 1 shared paper, 2024 · strength 0.18
  9. Kuirong Jiang · 1 shared paper, 2024 · strength 0.18
  10. Chunyang Lv · 1 shared paper, 2021 · strength 0.12
  11. Zheng Wang · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.